Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD2 | P14416 | 2/20 | 0.35 |
| ▸ | MAOA | P21397 | 1/20 | 0.34 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.33 |
| ▸ | BCHE | P06276 | 1/20 | 0.32 |
| ▸ | MGLL | Q99685 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 2/20 | 0.31 |
| ▸ | ESR1 | P03372 | 2/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.31 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | ACMSD | Q8TDX5 | 1/20 | 0.31 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | USP2 | O75604 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21149098 | 0.90 | CYP11B2 (0.40) | DRD2 | |
| SCHEMBL21149810 | 0.86 | MGLL (0.35) | DRD2MAOAALOX5BCHEMGLL | |
| SCHEMBL16890262 | 0.84 | DRD2 (0.30) | DRD2 | |
| SCHEMBL23432165 | 0.84 | — | — | |
| SCHEMBL24137555 | 0.83 | DRD2 (0.32) | DRD2 | |
| SCHEMBL21150628 | 0.82 | RXRB (0.39) | DRD2HSD17B2 | |
| SCHEMBL16890230 | 0.81 | BCHE (0.32) | DRD2BCHEMGLLALDH1A1HSP90AA1 | |
| SCHEMBL22874437 | 0.81 | BCHE (0.32) | DRD2BCHEMGLLALDH1A1HSP90AA1 | |
| SCHEMBL22181738 | 0.79 | — | — | |
| SCHEMBL16890309 | 0.78 | DRD2 (0.31) | DRD2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11139437-B2 | Compound and organic electroluminescence device | IDEMITSU KOSAN CO., LTD. (JP) | 2021-10-05 | — | — | US | disclosed |
| US-20200035922-A1 | ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2020-01-30 | — | — | US | disclosed |
| US-20190214579-A1 | NOVEL COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2019-07-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11139437-B2 | Compound and organic electroluminescence device | RIF1, OR10J3, LEF1 | DRD2 1886/4885MAOA 1850/4885ALOX5 3610/4885 |
| US-20190214579-A1 | NOVEL COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE | PIEZO1, RIF1, OR10J3 | DRD2 1601/4885MAOA 1596/4885ALOX5 3346/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.